Trial Profile
Optimizing the Performance of ALTROPANE SPECT Imaging in Patients With Parkinson Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2016
Price :
$35
*
At a glance
- Drugs NAV 5001 (Primary)
- Indications Parkinson's disease
- Focus Diagnostic use
- Sponsors Molecular NeuroImaging
- 18 May 2014 New trial record